Cardiology

Trials, guidelines and practice across cardiovascular medicine.

C-QIP improves cardiovascular secondary prevention in India feasibility trial

A multicomponent care strategy improved guideline-directed therapy and self-reported adherence for chronic cardiovascular disease in Indian outpatient clinics.

By Dr. Aishwarya N., MBBS · Oct 19, 2026 · 5 min read

Cardiology·DailyMed

Sacubitril and Valsartan Label Expands Pediatric and Adult Heart Failure Guidance

Updated U.S. labeling clarifies dosing, pediatric use, and safety warnings for sacubitril and valsartan in heart failure.

Oct 19, 2026

Cardiology·Cancer Disc

Anthracycline Cardiotoxicity Linked to TOP2B Upregulation in Preclinical Study

Preclinical data identify TOP2B upregulation and SMYD1 disruption as a new anthracycline cardiotoxicity mechanism, with ASO protection in…

Oct 19, 2026

Cardiology·JAMA Card

Microgravity VTE review finds no direct anticoagulant evidence in astronauts

A systematic review found no direct studies of anticoagulants in microgravity, leaving astronaut VTE prevention dependent on physiologic…

Oct 19, 2026

Cardiology·JNCI

Lipid-Lowering Drugs Show Limited Benefit in Heart Failure

A JNCI review finds statins and other lipid-lowering drugs are not harmful in heart failure, but outcome benefits…

Oct 19, 2026

Cardiology·EHJ

Obstetric antiphospholipid syndrome criteria examined in ambispective cohort study

European Heart Journal study evaluated how well obstetric antiphospholipid syndrome classification criteria performed in an ambispective cohort.

Oct 19, 2026

Cardiology·EHJ

Outpatient Antibiotic Fills After Endocarditis Discharge in Medicaid Cohort

A national Medicaid cohort study examined outpatient antibiotic fills and 30-day readmission after patient-directed discharge for drug use-associated…

Oct 19, 2026

Cardiology·Nature